Biotechnology Analysts discuss Roche (RHHBY) Diagnostics on the future of sequencing on an Analyst/Industry conference call to be held on March 25.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY:
- Roche receives CE Mark for Elecsys Apolipoprotein E4 test
- Roche price target lowered to CHF 325 from CHF 350 at JPMorgan
- Xencor reports receipt of notice of termination of license agreement from Roche
- H.C. Wainwright does not see direct read from Roche miss to Olema’s OPERA-02
- Genentech announces persevERA Breast Cancer study did not meet primary endpoint